Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Aquae who knows? There will be hell to pay if the Sweetbiotix deal is not with at least one global.
Had a quick reread of last year's interims. Obviously we will get detailed breakdown of the costs. Which will show how gross margin is doing.
Last time around there was nothing re post period revenues. Just a generally positive comment on FY. And further general comments re commercial progress and hopes for the future.
Perhaps best not to get too excited, whenever interims appear.
Direcons, mindful the first mention since the original announcement in 2018, that the company is working with another partner for some of its sweetbiotix products appeared in August this year, are we sure it is still the original partner that had only a 6mth exclusivity agreement at the time that is now being referenced?
Re. Cargill, this was suggested at the time of the announcement below, and Cargill fit the bill perfectly. The $100bn turnover was a massive clue. However, the Sweetbiotix offering differs from the one you mention, because Sweetbiotix, although a soluble fiber, is also a functional fiber ie. it offers health benefits as well as being a natural sweetener. The Holy Grail.........we hope!
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces that it has entered into an agreement with a global corporate for its SweetBiotix® low calorie sweet fibres. The agreement sets out the terms and grants exclusivity, for a period of six months, to negotiate a license agreement for the scale up, manufacture and distribution of its SweetBiotix® low calorie sweet fibres. OptiBiotix will receive monthly payments during this exclusivity period amounting to a six figure sum.
OptiBiotix has previously announced (RNS: 27 March 2018) that it has carried out five successful human taste studies on a range of products developed from its SweetBiotix® development programmes. This has created interest from a number of corporates with expertise in the manufacture and commercialisation of speciality ingredients and/or consumer products. This agreement reflects the materialisation of interest from one of these companies in scaling up, manufacturing and distributing SweetBiotix® from one of its development programmes.
The company is a global supplier of nutritional and agricultural products to companies around the world with an annual turnover exceeding $100bn. The organisation requires its identity and the terms of the agreement to remain confidential and no further details can be disclosed. A further announcement will be made in due course.
Agree skid that the outlook will be the most interesting part to see confirmation of the acceleration of the H2 revenue growth predicted in the Trading update in August. Also any news on sweetbiotix would be very welcome; are we still on track for news this calendar year?
"SweetBiotix: The Company is progressing industrial scale up of a number of its innovative SweetBiotix products with its US partner and working with a number of corporates with leading positions in the Food & Beverages markets who have signed Material Transfer Agreements to develop applications. The Company is also working with one of the world's leading companies in taste and sweetness on jointly scaling up and commercialising another group of SweetBiotix products"
Pure speculation on my part but did wonder if the latter partner could be Cargill when I saw this update which included a paragraph about their "next generation fibers" but probably barking up the wrong tree
"The patented technology will also enable Cargill to produce next generation fibers. As with the initial offerings, these future soluble fibers will address key market needs targeting sugar and fat reduction."
https://www.cargill.com/2021/cargill-enters-european-soluble-fiber-market-with-$45-million
Thanks, will read these with interest, post period events and forward view will be the interesting read rather than results.
That looks correct.
According to the H&L Financial Calendar, Optis Interim Results are out Thursday